Insulin use, which is common in up to one-third of DM patients (Trief et al., 2016), is an independent risk factor for the development of heart failure (Nichols et al., 2004; Wang et al., 2015) and LV dysfunction (Hirose et al., 2021). The gene discussed is INS; the disease is heart failure.